Cargando…
Prevalence of Metabolic Syndrome in Psoriasis and Levels of Interleukin-6 and Tumor Necrosis Factor-α in Psoriasis Patients with Metabolic Syndrome: Indian Tertiary Care Hospital Study
BACKGROUND: Psoriasis is a chronic inflammatory multisystem disease, found to be associated with metabolic syndrome (MS) and increased levels of cytokines. To evaluate the prevalence of MS in psoriasis and to determine the levels of interleukin-6 (IL-6) and tumor necrosis factor-α (TNF-α) in psorias...
Autores principales: | Singh, Surjit, Dogra, Sunil, Shafiq, Nusrat, Bhansali, Anil, Malhotra, Samir |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Medknow Publications & Media Pvt Ltd
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5590379/ https://www.ncbi.nlm.nih.gov/pubmed/28904916 http://dx.doi.org/10.4103/ijabmr.IJABMR_330_16 |
Ejemplares similares
-
Randomized Placebo Control Study of Metformin in Psoriasis Patients with Metabolic Syndrome (Systemic Treatment Cohort)
por: Singh, Surjit, et al.
Publicado: (2017) -
Randomized placebo control study of insulin sensitizers (Metformin and Pioglitazone) in psoriasis patients with metabolic syndrome (Topical Treatment Cohort)
por: Singh, Surjit, et al.
Publicado: (2016) -
Psoriasis and Metabolic Syndrome
por: Malkic Salihbegovic, Eldina, et al.
Publicado: (2015) -
Level of inflammatory cytokines tumour necrosis factor α, interleukins 12, 23 and 17 in patients with psoriasis in the context of metabolic syndrome
por: Pirowska, Magdalena, et al.
Publicado: (2019) -
Psoriasis and metabolic syndrome: implications for the management and treatment of psoriasis
por: Wu, J.J., et al.
Publicado: (2022)